| Date | Time | Source | | | 06/10/2010 | 2:42AM | DJN | Uk Coal Plc Statement Re Hargreaves Services Plc
TIDMUKC TIDMHSP RNS Number : 3688N UK Coal PLC 10 June 2010 ? 10 June 2010 UK COAL PLC Statement regarding Hargreaves Services plc UK COAL plc ("UK COAL" or "The Group") announces that, further to the announcement of 9 March 2010 and the subsequent announcement of 26 April 2010, it has received confirmation from Hargreaves... More...>> |
| 06/10/2010 | 2:42AM | DJN | Hargreaves Servs Plc Statement Regarding Uk Coal
TIDMHSP TIDMUKC RNS Number : 3797N Hargreaves Services PLC 10 June 2010 ? +------------------------------+------------------------------+ | For Immediate Release | 10 June 2010 | | | | +------------------------------+------------------------------+ Hargreaves Services plc Statement regarding UK Coal plc On 10 March 2010... More...>> |
| 04/26/2010 | 5:17AM | DJN | UPDATE: UK Coal Seeks Farmland Buyers As Loss Widens
Coal producer UK Coal PLC (UKC.LN) Monday reported a wider full-year loss because of production problems and property losses, and said it plans to sell thousands of acres of farmland in England to pay down its debts. UK Coal, which supplies coal to customers including Scottish & Southern Energy PLC (SSE.LN), added... More...>> |
| 04/26/2010 | 3:00AM | DJN | Hargreaves Servs Plc Statement Re: Uk Coal
TIDMHSP TIDMUKC RNS Number : 7466K Hargreaves Services PLC 26 April 2010 ? +-------------------------------+-------------------------------+ | For Immediate Release | 26 April 2010 | +-------------------------------+-------------------------------+ HARGREAVES SERVICES PLC Statement in response to UK Coal plc announcement... More...>> |
| 02/10/2010 | 9:57AM | PRNUS | Hospira Announces Expiration of Hart-Scott-Rodino Review Period for Acquisition of Orchid's Generic Injectable Pharmaceuticals B
-- Anticipates Closing the Transaction in March -- LAKE FOREST, Ill., Feb. 10 /PRNewswire-FirstCall/ -- Hospira, Inc., (NYSE: HSP), the world leader in generic injectable pharmaceuticals, and Orchid Chemicals & Pharmaceuticals Ltd. (BSE:524372BSE:NSE:BSE:ORCHIDCHEM), a leading Indian pharmaceuticals company, today announced... More...>> |
| 02/04/2010 | 7:27AM | PRNUS | Hospira Reports Fourth-Quarter and Full-Year 2009 Results
-- Provides Sales and Earnings Projections for 2010 -- LAKE FOREST, Ill., Feb. 4 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today reported results for the fourth quarter and full year ended Dec. 31, 2009. For the fourth quarter of 2009... More...>> |
| 01/29/2010 | 4:42PM | PRNUS | Hospira to Host Conference Call for Fourth-Quarter 2009 Results and 2010 Projections
LAKE FOREST, Ill., Jan. 29 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, will host a conference call to discuss its fourth-quarter and full-year 2009 results and projections for 2010 on Thursday, Feb. 4, 2010, at 8 a.m. Central time. The... More...>> |
| 01/22/2010 | 4:32PM | PRNUS | Hospira Supports Disaster Relief Efforts in Haiti With Products and Cash Grants
-- Company provides $1.5 million in urgently needed medical supplies; Donates $250,000 in cash grants -- LAKE FOREST, Ill., Jan. 22 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, and its philanthropic arm, the Hospira Foundation, have made... More...>> |
| 01/11/2010 | 10:37AM | PRNUS | Hospira to Present at J.P. Morgan 28th Annual Healthcare Conference Jan. 13, 2010
LAKE FOREST, Ill., Jan. 11 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today announced that the company will present at the J.P. Morgan 28th Annual Healthcare Conference on Wednesday, Jan. 13, 2010, in San Francisco. (Logo: http://www.newscom.com/cgi-bin/prnh/20040503/HSPLOGO... More...>> |
| 12/23/2009 | 3:00PM | PRNUS | Hospira to Present at J.P. Morgan 28th Annual Healthcare Conference Jan. 13, 2010
LAKE FOREST, Ill., Dec. 23 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today announced that the company will present at the J.P. Morgan 28th Annual Healthcare Conference on Wednesday, Jan. 13, 2010, in San Francisco. The presentation is... More...>> |
| 12/16/2009 | 1:30PM | PRNUS | Hospira to Host Conference Call for Fourth-Quarter 2009 Results and 2010 Projections
LAKE FOREST, Ill., Dec. 16 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today announced that it will host a conference call to discuss its fourth-quarter and full-year 2009 results and projections for 2010 on Thursday, Feb. 4, 2010, at 8... More...>> |
| 12/04/2009 | 11:06AM | PRNUS | Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers
- Containers Now Available in 50 mL and 100 mL Sizes and Include Improved Environmental Features - LAKE FOREST, Ill., Dec. 4 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today announced the launch of its next-generation 50 mL and 100 mL VisIV(TM... More...>> |
| 12/02/2009 | 11:32AM | PRNUS | Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings
-- Enterprise-wide system provides critical support to track H1N1 and other hospital infections -- LAKE FOREST, Ill., Dec. 2 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a leading provider of clinical information and medication delivery technologies, announced today that it has acquired Salt Lake City-based TheraDoc... More...>> |
| 11/11/2009 | 2:41PM | PRNUS | Arnold & Itkin Announces Lawsuits Over Defective Pain Pumps
HOUSTON, Nov. 11 /PRNewswire/ -- The Houston trial law firm Arnold & Itkin LLP has filed five lawsuits against the makers of pain pumps and related medications based on claims that many of the companies' defective devices are causing irreversible shoulder damage among patients. Currently, the attorneys at Arnold & Itkin... More...>> |
| 11/06/2009 | 5:36PM | PRNUS | Hospira to Present at Piper Jaffray 21st Annual Health Care Conference Dec. 2
LAKE FOREST, Ill., Nov. 6 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today announced that the company will present at the Piper Jaffray 21st Annual Health Care Conference on Wednesday, Dec. 2, 2009 in New York City. The presentation is... More...>> |
| 10/27/2009 | 11:45AM | DJN | 2nd UPDATE: Hospira 3Q Profit Jumps 42% Behind Generic Drug
(Adds details on results, executive comments, updated share price.) By Jon Kamp Of DOW JONES NEWSWIRES Hospira Inc.'s (HSP) third-quarter profit jumped 42%, beating analyst' expectations by a wide margin as a new generic version of a Sanofi-Aventis SA (SNY, SAN.FR) colon-cancer drug quickly ramped up sales. It looks like... More...>> |
| 10/27/2009 | 9:58AM | DJN | UPDATE: Hospira 3Q Profit Jumps 42%; EPS View Raised
By Jon Kamp Of DOW JONES NEWSWIRES Hospira Inc.'s (HSP) third-quarter profit jumped 42% as results surged ahead of analysts' expectations with help from a generic version of a Sanofi-Aventis SA (SNY, SAN.FR) colon-cancer drug and a cost-cutting plan. The maker of injectable drugs and medical devices boosted its already... More...>> |
| 10/27/2009 | 9:42AM | DJN | CORRECT: Hospira 3Q Results Surge Past Analysts' Expectations
("Hospira 3Q Results Surge Past Analysts' Expectations," published at 7:54 a.m. EDT, misstated global sales growth for Hospira's specialty injectable drug business. A corrected story follows.) DOW JONES NEWSWIRES Hospira Inc.'s (HSP) third-quarter profit jumped 42% as results smashed analysts' expectations in part due... More...>> |
| 10/27/2009 | 8:24AM | DJN | Hospira 3Q Results Surge Past Analysts' Expectations
DOW JONES NEWSWIRES Hospira Inc.'s (HSP) third-quarter profit jumped 42% as results smashed analysts' expectations in part due to the introduction of a generic cancer agent. The company, whose products range from injectible drugs to blood-monitoring devices, also raised its 2009 earnings forecast to $2.85 to $2.90 a share... More...>> |
| 10/27/2009 | 7:34AM | PRNUS | Hospira Reports Third-Quarter 2009 Results
-- Affirms recently increased 2009 sales projections and increases earnings guidance -- LAKE FOREST, Ill., Oct. 27 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today reported results for the third quarter ended Sept. 30, 2009. Net sales for... More...>> |
|